Observational studyTargeted oncology2019
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.
Emanuel Raschi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
51 papers cite it
this paperpooled itcites it